Feasibility, safety and tolerability of estrogen and/or probiotics for improving vaginal health in Canadian African, Caribbean, and Black women: A pilot phase 1 clinical trial.

Background: A dysbiotic vaginal microbiome (VMB) is associated with clinical conditions such as bacterial vaginosis (BV) and an increased risk of human immunodeficiency virus (HIV-1) infection. Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.

Methods: ACB women aged 18-49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.

Corrigendum: Preoperative Anxiolysis and Treatment Expectation (PATE Trial): open-label placebo treatment to reduce preoperative anxiety in female patients undergoing gynecological laparoscopic surgery - study protocol for a bicentric, prospective, randomized-controlled trial.

[This corrects the article DOI: 10.3389/fpsyt.2024.

Non-evaporative heat dissipation across the beaks and casques of large forest hornbills.

Heat loss across the beak is an important thermoregulatory mechanism among birds, particularly in large-beaked taxa such as toucans (Ramphastidae) and hornbills (Bucerotidae). The number of species investigated remains limited, as does our understanding of how the functional significance of this pathway varies with environmental variables such as humidity, with little previous research on species inhabiting humid environments. We used infrared thermography to test the hypothesis that large (600-1300 g) Afrotropical forest hornbills use their beaks and casques as thermal radiators.

Pilot Study of IL-1 Antagonist Anakinra for Treatment of Endometriosis.

Purpose: To evaluate the impact of an interleukin-1 (IL-1) antagonist anakinra (Kineret) on endometriosis-related quality of life (QoL), pain, and inflammatory biomarkers.

Methods: This was a single-site, randomized, double-blinded, placebo-controlled, cross-over pilot clinical study of patients recruited at an academic specialty clinic. Eligible participants were females aged 18-45 years with menstrual cycles every 24-32 days.